![Kirk Daffner, M.D. featured in article, “Alone in the Spotlight but not alone”](https://cbmm.bwh.harvard.edu/wp-content/uploads/2024/07/Screenshot-2024-07-26-at-2.56.55 PM.png)
Kirk Daffner, M.D. featured in article, “Alone in the Spotlight but not alone”
Cognitive neurologist sees value in age-focused conversations around Biden’s exit, but also a lack of nuance
Cognitive neurologist sees value in age-focused conversations around Biden’s exit, but also a lack of nuance
Study suggests genetics are a cause, not just a risk for some with Alzheimer’s.
Patients planning to receive anti-amyloid treatments such as lecanemab first must enroll in a registry to help clinicians draw conclusions on the drugs’ safety and efficacy.
Dr. Megan Richie, neurohospitalist at UCSF, spoke to Dr. Seth A. Gale, Co-Director of the Brain Health Program and Assistant Professor of Neurology at Harvard Medical School.